Form 4 for APYX Apyx Medical Corp
Accepted 2026-07-02 17:00:23 ET · period of report 2026-06-30 · accession 0001493152-26-031944 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2026-07-02 17:00 | 2026-06-30 | APYX | Waldman Lawrence | Dir | M - OptEx | $1.88 | +12.0K | 17.3K | +225% | +$22.6K |
| DI | 2026-07-02 17:00 | 2026-06-30 | APYX | Waldman Lawrence | Dir | F - Tax | $4.49 | -5,024 | 12.3K | -29% | -$22.6K |
| DI | 2026-07-02 17:00 | 2026-06-30 | APYX | Waldman Lawrence | Dir | M - OptEx | $0.00 | -12.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-30 | M | A | 12,000 | $1.88 | 17,338 | I By SLAT | — | — | (F1) Held by a Spousal Lifetime Access Trust (the "SLAT"). The Reporting Person's spouse and children are trustees of the SLAT. The Reporting Person disclaims beneficial ownership of all securities held by the SLAT, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein, if any. |
| 2 | Common | Common Stock | 2026-06-30 | F | D | 5,024 | $4.49 | 12,314 | I By SLAT | — | — | (F1) Held by a Spousal Lifetime Access Trust (the "SLAT"). The Reporting Person's spouse and children are trustees of the SLAT. The Reporting Person disclaims beneficial ownership of all securities held by the SLAT, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein, if any. |
| 3 | Derivative | Stock option (right to buy) | 2026-06-30 | M | D | 12,000 | $0.00 | 0 | I By SLAT | $1.88 · — to 2026-07-28 | 12,000 Common Stock | (F2) On June 30, 2026, the Reporting Person effected a net exercise of 12,000 stock options with an exercise price of $1.88 per share. Pursuant to the terms of the exercise, 5,024 shares otherwise issuable upon exercise were withheld by the issuer at a value of $4.49 per share to satisfy the aggregate exercise price, resulting in the issuance of 6,976 net shares to the Reporting Person. (F1) Held by a Spousal Lifetime Access Trust (the "SLAT"). The Reporting Person's spouse and children are trustees of the SLAT. The Reporting Person disclaims beneficial ownership of all securities held by the SLAT, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein, if any. |